Argireline vs Leuphasyl

Head-to-head comparison of Argireline (Acetyl Hexapeptide-3) and Leuphasyl (Pentapeptide-18) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyArgirelineLeuphasyl
CategorySkin & CosmeticSkin & Cosmetic
Full NameAcetyl Hexapeptide-3Pentapeptide-18
Molecular Weight889.0 Da569.6 Da
Half-LifeN/AN/A
Amino Acids65
Typical Dose0.005-10% in finished cosmetic products0.01-2% in cosmetic formulations
RouteTopicalTopical
Purity≥98%≥98%
Studies Count4822
Research StatusClinicalClinical

Argireline Benefits

  • ✓expression-line softening
  • ✓anti-wrinkle support
  • ✓cosmetic skin smoothing
  • ✓topical peptide stacking

Leuphasyl Benefits

  • ✓wrinkle-appearance reduction
  • ✓expression-line softening
  • ✓topical anti-aging support
  • ✓cosmetic skin-smoothing

Argireline Dosing

Topical serum/cream 0.005-10%|Apply 1-2x daily to clean skin|Use consistently for 4-12 weeks

Leuphasyl Dosing

Topical serum/cream 0.01-2%|Apply once or twice daily|Combine with moisturizer or peptide serum

Argireline Side Effects

  • ⚠mild stinging
  • ⚠redness or irritation
  • ⚠allergic contact dermatitis

Leuphasyl Side Effects

  • ⚠temporary redness
  • ⚠mild irritation
  • ⚠sensitivity in compromised skin

Research Overview

Argireline

Acetyl hexapeptide-3 has both in vitro and small human-cosmetic studies supporting a reduction in wrinkle depth or wrinkle appearance. Its best-supported role is as a topical cosmetic peptide rather than a systemic drug.

Leuphasyl

Pentapeptide-18 has published cosmetic and formulation literature supporting its use in anti-aging skincare. Evidence is strongest for topical cosmetic smoothing rather than deep structural remodeling.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Argireline stacks with:

Hyaluronic AcidNiacinamideCeramides

Leuphasyl stacks with:

RetinoidsHyaluronic AcidPeptide Complexes
anti-wrinkletopicalcosmetic-peptideexpression-linespeptide